Psyence Biomedical Ltd.

US$2.96As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PBMHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (85.68%)
Div yield —
ROE (58.62%)
Biotechnology
Beta (5Y) 1.73
PE TTM —
TSR TTM (85.01%)
Mkt cap US$11.29M
ROIC (32.95%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.21
8.40%
(16.48%)
Hold 3|0|10|1|12
3Q26
4Q26
1Q27
2Q27
Earnings per share$
0.03
0.03
0.03
0.03
10.86%
7.48%
(4.04%)
1.86%
Revenue$M
1.225
1.214
1.190
1.187
(1.68%)
(0.38%)
(3.55%)
(1.22%)
Peers (US$11.29M)
Cap (US$)
PE
11.33M
—
Capital
TTM
5Y
10Y
Leveragex
1.772
0.142
0.100
EBIT/Intx
4.439
0.219
0.219
Own earn%
3.68
(105.82)
(103.80)
Sh yield%
49.44
14.48
13.02
Owners
Insiders/Inst%
14.46
38.35
Short interest%
1.67
SBC / revenue%
5.86
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
19–24
$1 testx
—
Incr. ROIC%
22